InspireMD Inc. NSPR 深 沪
等待开盘 06-26 09:30:00 美东时间
0.655
-0.045
-6.44%
华盛通- 最 高0.7399
- 今 开0.7038
- 成交量 17.34万股
- 最 低 0.645
- 昨 收 0.7001
- 总市值 3067.95万
- 52周最高 2.9319
- 市盈率 静 --
- 换手率 0.37%
- 52周最低 0.645
- 委 比 -81.43%
- 总股本 4683.90万
- 历史最高 27890625.00
- 量 比 2.01
- 振 幅 13.56%
- 历史最低 0.645
- 每 手 1
- 风险率 0.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>InspireMD, Inc. announced that its Compensation Committee approved inducement grants of 91,161 restricted stock shares to six new non-executive employees, outside its 2021 Equity Incentive Plan, under the 2024 Inducement Plan. The restricted stock vests over three years, with one-third vesting annually on the first, second, and third anniversaries of the grant date, contingent on continued employment. The grants aim to incentivize new hires in...
06-12 20:05
InspireMD Announces First Patient Enrolled In CGUARDIANS III Pivotal Study Of SwitchGuard Neuro Protection System, For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the first patient has been enrolled in the
06-08 20:04
InspireMD Balances Fast Growth With U.S. Setback
InspireMD Inc (($NSPR)) has held its Q1 earnings call. Read on for the main hig...
05-11 08:21
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Transcript: InspireMD Q1 2026 Earnings Conference Call
InspireMD (NASDAQ:NSPR) released first-quarter financial results and hosted an ...
05-05 05:14
InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 27.27 percent increase over losses of $(0.22) per share from the
05-05 04:09
Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
InspireMD ( ($NSPR) ) has provided an update. InspireMD, Inc., a developer of c...
05-02 04:45
InspireMD Initiates Voluntary Recall For Its CGuard Prime 135 Cm Carotid Stent Delivery System
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD," or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that, in consultation with the U.S. Food and Drug
05-02 04:08
InspireMD Says FDA Approves IDE Application To Initiate CGUARDIANS III Pivotal Study Of SwitchGuard NPS, Including Next Gen Enhancements From Prior IDE Approval For Use With CGuard Prime 80 cm Stent Platform, In TCAR Procedures
InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the U.S. Food and Drug Administration ("FDA") has
05-02 04:07
